media – Page 497 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Therapy Against Progeria

After conducting a clinical trial study at Boston Children’s Hospital, scientists from Brown University recommended that a lonafarnib therapy could increase the survival rate of progeria patients. But the mode of action of lonafarnib is still uncertain.
- Source: Ddu
- 530
- June 7, 2018
progeria rare diseases Researches
IPO Filed by Translate for Undertaking Fibrosis Treatment Trial

An IPO for raising USD 115 million from public investors has been filed by Translate Bio. Proceeds garnered from the IPO will be used by Translate to trial an mRNA candidate designed to allow cystic fibrosis patients produce CTFR proteins.
- Source: Ddu
- 577
- June 6, 2018
Clinical Trials cystic fibrosis
Lynparza and Zytiga Combo Effective Against Prostate Cancer

Along with new drug partner Merck, the British drugmaker displayed results showing that adding Lynparza to Johnson & Johnson prostate cancer fighter Zytiga was a more potent disease-fighter than Zytiga alone. As compared to a time-frame of 8.2 months for solo Zytiga, the combo effectively prevented disease progression for 13.8 months.
- Source: Ddu
- 760
- June 6, 2018
AstraZeneca Clinical Trials Company Insight prostate cancer
How Much is Too Much Caffeine?

Kathleen Miller, an energy-drink specialist from the University at Buffalo Research Institute on Addictions said, "Caffeine can be a great thing, at low doses; with the consumption of five 5-hour Energy drinks, however, you move past alert and awake, into the territory of jittery, anxious and heart palpitations." Caffeine doses higher than 5000 mg can lead to seizures, hallucinations and strokes.
- Source: Ddu
- 566
- June 6, 2018
caffiene health tips Researches
Avoid Green Tea with an Iron Rich Diet

The major component named epigallocatechin-3-gallate (EGCG) in green tea inhibits myeloperoxidase enzymes released by white blood cells during inflammatory bowel disease outbursts. But when green tea was consumed with iron, EGCG bound with the iron and the ability to inhibit myeloperoxidase was lost.
- Source: Ddu
- 477
- June 6, 2018
diet health tips Researches
Discovery of Natural Blackcurrant Hair Dye

Hair dye poisoning is one of the major causes of self-injury. Chemical hair dye, especially paraphenylene-diamine can lead to edemas, rhabdomyolysis, acute metabolic acidosis and renal failure. Scientists from the University of Leeds have extracted natural dyes from blackcurrant waste, generated throughout Ribena blackcurrant production. This natural black dye with zero side effects could be used in fresh new hair dyeing technologies.
- Source: Ddu
- 461
- June 6, 2018
hair Researches toxicity
Invention of Antimicrobial Medical Gloves

Professor James, the lead researcher said, “These gloves will be a game-changer for the healthcare industry, both public and private. I am delighted that my lifetime’s research into bacteria and antibiotic resistance has directly informed the science behind a practical tool that will have a major impact on medical care in the future.”
- Source: Ddu
- 512
- June 6, 2018
medical device products Researches
Adaptimmune Lends Credence to T-Cell Therapy

Updated clinical data on its T-cell therapies has been presented by Adaptimmune. The GlaxoSmithKline-partnered NY-ESO SPEAR T-cells have been linked by the latest readouts to a 50% partial response rate in heavily pretreated cancer patients and have led to the positioning of Adaptimmune for dialing up of dosing of two wholly owned assets.
- Source: FierceBiotech
- 574
- June 5, 2018
Company Insight GSK T-cell therapies
Pneumonia Detection mHealth Wearable

Researchers are testing an mHealth wearable used for patients with asthma to see if the patch can help care teams detect pneumonia in patients undergoing radiation treatment for lung cancer.
- Source: mHealth Intelligence
- 847
- June 5, 2018
Clinical Trials mHealth pneumonia wearables
Parachute Health Received $9.5 Million Funding for ePrescribing Platform

The New York-based startup is aiming to digitize the equipment and to make the process easier through the ePrescribing platform. That way, the hospital doesn't spend time on faxing to communicate the order, and the patients and healthcare suppliers can get it quicker than they might have otherwise.
- Source: Business Insider
- 504
- June 5, 2018
Company Insight EHR

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.